Institutional Ownership
Wuxi Biologics Cayman Adr
CUSIP 98260N108Common StockWXXWYQ1 2026
13D / 13G Filings
0
Schedule 13D/13G on record
Beneficial Filers
0
Distinct reporting persons
Largest Stake
—
Max % of class reported
Institutional Holders
6
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
Schedule 13D (activist) & 13G (passive) 5%+ ownership filings
No 13D/13G filings on record yet
Schedule 13D/13G beneficial-ownership filings from 2020–present are ingested from SEC EDGAR. Coverage expands as the backfill and daily crawler run.
Top Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Rhumbline Advisers | 9.6K | $82.6K |
| 2 | Pnc Financial Services Group, Inc. | 3.9K | $33.8K |
| 3 | Accent Capital Management, LLC | 3.9K | $33.4K |
| 4 | Westside Investment Management, Inc. | 2.2K | $20.0K |
| 5 | Gamma Investing LLC | 1.6K | $13.7K |
| 6 | Ima Advisory Services, Inc. | 24 | $205 |